MA29680B1 - VACCINE - Google Patents

VACCINE

Info

Publication number
MA29680B1
MA29680B1 MA30332A MA30332A MA29680B1 MA 29680 B1 MA29680 B1 MA 29680B1 MA 30332 A MA30332 A MA 30332A MA 30332 A MA30332 A MA 30332A MA 29680 B1 MA29680 B1 MA 29680B1
Authority
MA
Morocco
Prior art keywords
vaccine
protocol
kit according
adjuvant
mpl
Prior art date
Application number
MA30332A
Other languages
French (fr)
Inventor
Brigitte Desiree Alberte Colau
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0509010A external-priority patent/GB0509010D0/en
Priority claimed from PCT/EP2005/006461 external-priority patent/WO2005123125A1/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of MA29680B1 publication Critical patent/MA29680B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

24. Utilisation, procédé, protocole, vaccin ou trousse selon l'une quelconque des revendications précédentes, où la protéine L1 de HPV est sous la forme d'une particule analogue à un virus. 25. Utilisation, procédé, protocole, vaccin ou trousse selon l'une quelconque des revendications précédentes, où le premier ou le deuxième vaccin ou les deux comprennent un adjuvant. 26. Utilisation, procédé, protocole, vaccin ou trousse selon la revendication 25, où l'adjuvant comprend du 3D-MPL. 27. Utilisation, procédé, protocole, vaccin ou trousse selon la revendication 25, où l'adjuvant comprend un sel d'aluminium. 28. Utilisation, procédé, protocole, vaccin ou trousse selon la revendication 26 ou 27, où l'adjuvant comprend un sel d'aluminium et du 3D MPL. 29. Utilisation, procédé, protocole, vaccin ou trousse selon la revendication 26, où l'adjuvant comprend un adjuvant en émulsion huile dans l'eau et du 3D-MPL. 30. Utilisation, procédé, protocole, vaccin ou trousse selon la revendication 29, où l'émulsion huile dans l'eau comprend une huile métabolisable, un stérol et un agent émulsionnant.Use, process, protocol, vaccine or kit according to any one of the preceding claims, wherein the HPV L1 protein is in the form of a virus-like particle. Use, process, protocol, vaccine or kit according to any one of the preceding claims, wherein the first or second vaccine or both comprise an adjuvant. Use, process, protocol, vaccine or kit according to claim 25, wherein the adjuvant comprises 3D-MPL. Use, process, protocol, vaccine or kit according to claim 25, wherein the adjuvant comprises an aluminum salt. Use, process, protocol, vaccine or kit according to claim 26 or 27, wherein the adjuvant comprises an aluminum salt and 3D MPL. Use, process, protocol, vaccine or kit according to claim 26, wherein the adjuvant comprises an oil-in-water emulsion adjuvant and 3D-MPL. Use, process, protocol, vaccine or kit according to claim 29, wherein the oil-in-water emulsion comprises a metabolizable oil, a sterol and an emulsifying agent.

MA30332A 2005-04-26 2007-10-29 VACCINE MA29680B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67482905P 2005-04-26 2005-04-26
GB0509010A GB0509010D0 (en) 2005-05-03 2005-05-03 Vaccine
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52

Publications (1)

Publication Number Publication Date
MA29680B1 true MA29680B1 (en) 2008-08-01

Family

ID=42334364

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30332A MA29680B1 (en) 2005-04-26 2007-10-29 VACCINE

Country Status (2)

Country Link
IL (1) IL186586A0 (en)
MA (1) MA29680B1 (en)

Also Published As

Publication number Publication date
IL186586A0 (en) 2008-01-20

Similar Documents

Publication Publication Date Title
Wieland et al. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ
AP1872A (en) Virus-like particles of human papillomavirus.
CA2443214A1 (en) Vaccine composition comprising human papilloma virus 16 l1 virus-like particle (hpv 16 l1 vlp), human papilloma virus 18 l1 virus-like particle (hpv 18 l1 vlp) and 3-de-o-acylatedmonphosphoryl lipid a (3d-mpl) and alum
BRPI0810959A2 (en) "hpv11 l1 protein, polynucleotide, vector, cell, composition, virus-like particle (vlp) hp11, method for producing an hpv l1 protein, vaccine for prevention of acuminate condyloma or hpv infections, use of the protein prevention method of acuminate condyloma or hpv infections and method for prevention of acuminate condyloma or hpv infections.
JP2011225578A5 (en)
HK1085378A1 (en) Use of hpv16 and hpv18 as vaccine against one or more of oncogenic hpv type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
EA200700338A1 (en) INHIBITORS OF RNA-DEPENDENT RNA POLYMERASE OF THE VIRUS HEPATITIS C AND COMPOSITIONS AND METHODS OF TREATMENT USING THEM
AU7812800A (en) Diagnosis method of fibrotic disease using biochemical markers
EP2340830A3 (en) Hepatitis C Virus Inhibitors
JP2003526673A5 (en)
EP2377551A3 (en) Adjuvanted influenza vaccines including cytokine-inducing agents
JP2006512413A5 (en)
SG160328A1 (en) Adjuvant composition comprising aluminium phosphate and 3d-mpl
MA29680B1 (en) VACCINE
SG153837A1 (en) Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52
ATE380034T1 (en) NEW METHOD FOR PRODUCING VIRUS-LIKE PARTICLES OF THE HUMAN PAPILLOMA VIRUS WITH IMPROVED PROPERTIES
TW200612983A (en) Vaccine
RU2016141621A (en) WAYS OF STRENGTHENING EFFECTIVENESS OF IMMUNITY OF VACCINES ADSORPED ON SALTS OF ALUMINUM
GB2555748A (en) Novel form of isoxadifen-ethyl, process for preparation and use thereof
EA200702077A1 (en) VACCINE
SI1572233T1 (en) Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
Li-ming Sporo-pollen assemblages from late phase of Early Cretaceous in Minhe Basin
NZ567982A (en) Influenza vaccines extemporaneously adsorbed to aluminium adjuvants
RU2452729C2 (en) Biphenyl derivatives and application thereof in treating hepatitis c
MA29679B1 (en) VACCINE